Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jan;40(1):244–246. doi: 10.1128/aac.40.1.244

Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses.

S Santavirta 1, M Takagi 1, Y T Konttinen 1, T Sorsa 1, A Suda 1
PMCID: PMC163093  PMID: 8787916

Abstract

The inhibitory effects of drugs on matrix metalloproteinase (MMP) activity in tissues around sites of loose total hip arthroplasty (THA) prostheses were studied. For activity measurements, a DNP-S (dinitrophenyl-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg) peptide degradation assay was performed by means of high-performance liquid chromatography. Neutral salt tissue extracts revealed significantly elevated MMP activity in THA samples compared with that in noninflamed synovial tissue from the knee joint. This elevation was markedly inhibited by cephalothin, but not by doxycycline, tetracycline, or gentamicin. These results indicate that cephalothin can inhibit MMP activity in reactive periprosthetic tissue and thus reduce, by a nonantimicrobial mechanism, the tissue destruction associated with the loosening of THA implants.

Full Text

The Full Text of this article is available as a PDF (150.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breedveld F. C., Dijkmans B. A., Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol. 1990 Jan;17(1):43–46. [PubMed] [Google Scholar]
  2. Bunning R. A., Murphy G., Kumar S., Phillips P., Reynolds J. J. Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur J Biochem. 1984 Feb 15;139(1):75–80. doi: 10.1111/j.1432-1033.1984.tb07978.x. [DOI] [PubMed] [Google Scholar]
  3. Clark I. M., Powell L. K., Ramsey S., Hazleman B. L., Cawston T. E. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993 Mar;36(3):372–379. doi: 10.1002/art.1780360313. [DOI] [PubMed] [Google Scholar]
  4. Goldring S. R., Clark C. R., Wright T. M. The problem in total joint arthroplasty: aseptic loosening. J Bone Joint Surg Am. 1993 Jun;75(6):799–801. doi: 10.2106/00004623-199306000-00001. [DOI] [PubMed] [Google Scholar]
  5. Golub L. M., Suomalainen K., Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent. 1992 Mar;2:80–90. [PubMed] [Google Scholar]
  6. Gray R. D., Saneii H. H. Characterization of vertebrate collagenase activity by high-performance liquid chromatography using a synthetic substrate. Anal Biochem. 1982 Mar 1;120(2):339–346. doi: 10.1016/0003-2697(82)90355-4. [DOI] [PubMed] [Google Scholar]
  7. Harris W. H., Schiller A. L., Scholler J. M., Freiberg R. A., Scott R. Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am. 1976 Jul;58(5):612–618. [PubMed] [Google Scholar]
  8. Ingman T., Sorsa T., Suomalainen K., Halinen S., Lindy O., Lauhio A., Saari H., Konttinen Y. T., Golub L. M. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol. 1993 Feb;64(2):82–88. doi: 10.1902/jop.1993.64.2.82. [DOI] [PubMed] [Google Scholar]
  9. Knight W. B., Green B. G., Chabin R. M., Gale P., Maycock A. L., Weston H., Kuo D. W., Westler W. M., Dorn C. P., Finke P. E. Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastase. Biochemistry. 1992 Sep 8;31(35):8160–8170. doi: 10.1021/bi00150a007. [DOI] [PubMed] [Google Scholar]
  10. Krane S. M. Clinical importance of metalloproteinases and their inhibitors. Ann N Y Acad Sci. 1994 Sep 6;732:1–10. doi: 10.1111/j.1749-6632.1994.tb24719.x. [DOI] [PubMed] [Google Scholar]
  11. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  12. Maragoudakis M. E., Peristeris P., Missirlis E., Aletras A., Andriopoulou P., Haralabopoulos G. Inhibition of angiogenesis by anthracyclines and titanocene dichloride. Ann N Y Acad Sci. 1994 Sep 6;732:280–293. doi: 10.1111/j.1749-6632.1994.tb24743.x. [DOI] [PubMed] [Google Scholar]
  13. Masui Y., Takemoto T., Sakakibara S., Hori H., Nagai Y. Synthetic substrates for vertebrate collagenase. Biochem Med. 1977 Apr;17(2):215–221. doi: 10.1016/0006-2944(77)90026-6. [DOI] [PubMed] [Google Scholar]
  14. Nishida M., Murakawa T., Kamimura T., Okada N., Fukada S. Laboratory evaluation of FR10024 a new cephalosporin derivative. Antimicrob Agents Chemother. 1977 Jan;11(1):51–63. doi: 10.1128/aac.11.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Okada Y., Takeuchi N., Tomita K., Nakanishi I., Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989 Aug;48(8):645–653. doi: 10.1136/ard.48.8.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sakamoto S., Sakamoto M. Degradative processes of connective tissue proteins with special emphasis on collagenolysis and bone resorption. Mol Aspects Med. 1988;10(4):299–428. doi: 10.1016/0098-2997(88)90025-8. [DOI] [PubMed] [Google Scholar]
  17. Santavirta S., Gristina A., Konttinen Y. T. Cemented versus cementless hip arthroplasty. A review of prosthetic biocompatibility. Acta Orthop Scand. 1992 Apr;63(2):225–232. doi: 10.3109/17453679209154831. [DOI] [PubMed] [Google Scholar]
  18. Santavirta S., Konttinen Y. T., Bergroth V., Eskola A., Tallroth K., Lindholm T. S. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am. 1990 Feb;72(2):252–258. [PubMed] [Google Scholar]
  19. Santavirta S., Sorsa T., Konttinen Y. T., Saari H., Eskola A., Eisen A. Z. Role of mesenchymal collagenase in the loosening of total hip prosthesis. Clin Orthop Relat Res. 1993 May;(290):206–215. [PubMed] [Google Scholar]
  20. Sato H., Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 1993 Feb;8(2):395–405. [PubMed] [Google Scholar]
  21. Scarpellini F., Scarpellini L., Sbracia M., Curto C. Effectiveness of a cephalosporin, cefotetan, in inhibition of uterine matrix metalloproteinases by a non-antibacterial mechanism. Ann N Y Acad Sci. 1994 Sep 6;732:495–496. doi: 10.1111/j.1749-6632.1994.tb24797.x. [DOI] [PubMed] [Google Scholar]
  22. Seltzer J. L., Eschbach M. L., Winberg J. O., Bauer E. A., Eisen A. Z., Weingarten H. Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates. Coll Relat Res. 1987 Dec;7(6):399–407. doi: 10.1016/s0174-173x(87)80038-9. [DOI] [PubMed] [Google Scholar]
  23. Sorsa T., Ding Y., Salo T., Lauhio A., Teronen O., Ingman T., Ohtani H., Andoh N., Takeha S., Konttinen Y. T. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci. 1994 Sep 6;732:112–131. doi: 10.1111/j.1749-6632.1994.tb24729.x. [DOI] [PubMed] [Google Scholar]
  24. Suomalainen K., Sorsa T., Saxén L., Vauhkonen M., Uitto V. J. Collagenase activity in gingival crevicular fluid of patients with juvenile periodontitis. Oral Microbiol Immunol. 1991 Feb;6(1):24–29. doi: 10.1111/j.1399-302x.1991.tb00447.x. [DOI] [PubMed] [Google Scholar]
  25. Takagi M., Konttinen Y. T., Lindy O., Sorsa T., Kurvinen H., Suda A., Santavirta S. Gelatinase/type IV collagenases in the loosening of total hip replacement endoprostheses. Clin Orthop Relat Res. 1994 Sep;(306):136–144. [PubMed] [Google Scholar]
  26. Takagi M., Konttinen Y. T., Santavirta S., Sorsa T., Eisen A. Z., Nordsletten L., Suda A. Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand. 1994 Jun;65(3):281–286. doi: 10.3109/17453679408995454. [DOI] [PubMed] [Google Scholar]
  27. Tsuchiya K., Kida M., Kondo M., Ono H., Takeuchi M., Nishi T. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1978 Oct;14(4):557–568. doi: 10.1128/aac.14.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vincenti M. P., Clark I. M., Brinckerhoff C. E. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 1994 Aug;37(8):1115–1126. doi: 10.1002/art.1780370802. [DOI] [PubMed] [Google Scholar]
  29. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  30. Yu L. P., Jr, Smith G. N., Jr, Brandt K. D., Myers S. L., O'Connor B. L., Brandt D. A. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum. 1992 Oct;35(10):1150–1159. doi: 10.1002/art.1780351007. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES